Skip to content
The Nexus
DossierENTITY

AVLN

Coverage of AVLN in the Nexus archive.

Earliest in view: Jun 3 · 12:10 UTCMost recent: Jun 3 · 12:10 UTC
Co-mentioned in this coverage
Avalyn Pharma Inc.organization1Bostonplace1Automated Insightsorganization1Zacks Investment Researchorganization1
Recent coverage
  • BUSINESSJun 3 · 12:10 UTCWTOP DC
    Avalyn: Q1 Earnings Snapshot

    Avalyn Pharma Inc. reported a $26.9 million loss in its first quarter, equivalent to $21.83 per share. The Boston-based company's earnings snapshot was generated by Automated Insights using data from Zacks Investment Research.